Treatment-related mortality among children with cancer in Denmark during 2001-2021
DOI:
https://doi.org/10.2340/1651-226X.2024.27731Keywords:
Treatment-related death, Cohort study, Register-based study, Paediatric cancerAbstract
Background: Survival of children with cancer has markedly improved over recent decades, largely due to intensified treatment regimes. The intensive treatment may, however, result in fatal complications. In this retrospective cohort study, we assessed temporal variation in the incidence of treatment-related death and associated risk factors among children diagnosed with cancer in Denmark during 2001–2021.
Method: Among all children diagnosed with first incident cancer before age 15 years recorded in the Danish Childhood Cancer Register (n = 3,255), we estimated cumulative incidence of treatment-related death (death in the absence of progressive cancer) within 5 years from diagnosis using Aalen–Johansen estimators and assessed associated risk factors using Cox regression.
Results: Among all 3,255 children with cancer, 93 (20% of all 459 deaths) died from treatment. Of these treatment-related deaths, 39 (42%) occurred within 3 months of diagnosis. The 5-year cumulative incidences of treatment-related death were 3.3% during 2001–2010 and 2.5% during 2011–2021 (p = 0.20). During 2011–2021, treatment-related deaths accounted for more than half of all deaths among children with haematological cancers. Risk factors varied according to cancer group and included female sex, age below 1 year at diagnosis, disease relapse, stem cell transplantation, central nervous system involvement, and metastasis at diagnosis.
Interpretation: Despite increasing treatment intensities, the incidence of treatment-related death has remained stable during the past 20 years in Denmark. Still, clinical attention is warranted to prevent treatment-related deaths, particularly among children with haematological cancers. Patient characteristics associated with increased treatment-related death risk support patient-specific treatment approaches to avoid these fatalities.
Downloads
References
Gatta G, Botta L, Rossi S, et al. Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5 – a population-based study. Lancet Oncol. 2014;15:35–47.
https://doi.org/10.1016/S1470-2045(13)70548-5 DOI: https://doi.org/10.1016/S1470-2045(13)70548-5
Bosetti C, Bertuccio P, Chatenoud L, et al. Childhood cancer mortality in Europe, 1970–2007. Eur J Cancer. 2010;46:384–94.
https://doi.org/10.1016/j.ejca.2009.09.011 DOI: https://doi.org/10.1016/j.ejca.2009.09.011
Bertuccio P, Alicandro G, Malvezzi M, et al. Childhood cancer mortality trends in Europe, 1990–2017, with focus on geographic differences. Cancer Epidemiol. 2020;67:1–10.
https://doi.org/10.1016/j.canep.2020.101768 DOI: https://doi.org/10.1016/j.canep.2020.101768
Erdmann F, Frederiksen LE, Bonaventure A, et al. Childhood cancer: survival, treatment modalities, late effects and improvements over time. Cancer Epidemiol. 2021;71:1–20.
https://doi.org/10.1016/j.canep.2020.101733 DOI: https://doi.org/10.1016/j.canep.2020.101733
Schulpen M, Visser O, Reedijk AMJ, et al. Significant improvement in survival of advanced stage childhood and young adolescent cancer in the Netherlands since the 1990s. Eur J Cancer. 2021;157:81–93.
https://doi.org/10.1016/j.ejca.2021.08.001 DOI: https://doi.org/10.1016/j.ejca.2021.08.001
Karim-Kos HE, Hackl M, Mann G, et al. Trends in incidence, survival and mortality of child-hood and adolescent cancer in Austria, 1994–2011. Cancer Epidemiol. 2016;42:72–81.
https://doi.org/10.1016/j.canep.2016.03.015 DOI: https://doi.org/10.1016/j.canep.2016.03.015
Molgaard-Hansen L, Möttönen M, Glosli H, et al. Early and treatment-related deaths in childhood acute myeloid leukaemia in the Nordic countries: 1984–2003. Br J Haematol. 2010;151:447–59.
https://doi.org/10.1111/j.1365-2141.2010.08389.x DOI: https://doi.org/10.1111/j.1365-2141.2010.08389.x
Tran TH, Lee M, Alexander S, et al. Lack of treatment-related mortality definitions in clini-cal trials of children, adolescents and young adults with lymphomas, solid tu-mors and brain tumors: a systematic review. BMC Cancer. 2014;14:1–5.
https://doi.org/10.1186/1471-2407-14-612 DOI: https://doi.org/10.1186/1471-2407-14-612
Lee JW, Lim DH, Sung KW, et al. Promising survival rate but high incidence of treatment-related mortality after reduced-dose craniospinal radiotherapy and tandem high-dose chemotherapy in patients with high-risk medulloblastoma. Cancer Med. 2020;9:5807–18.
https://doi.org/10.1002/cam4.3199 DOI: https://doi.org/10.1002/cam4.3199
Alexander S, Pole JD, Gibson P, et al. Classification of treatment-related mortality in chil-dren with cancer: A systematic assessment. Lancet Oncol. 2015;16:e604–10.
https://doi.org/10.1016/S1470-2045(15)00197-7 DOI: https://doi.org/10.1016/S1470-2045(15)00197-7
Loeffen EAH, Knops RRG, Boerhof J, et al. Treatment-related mortality in children with cancer: prevalence and risk factors. Eur J Cancer. 2019;121:113–22.
https://doi.org/10.1016/j.ejca.2019.08.008 DOI: https://doi.org/10.1016/j.ejca.2019.08.008
Pole JD, Gibson P, Ethier MC, et al. Evaluation of treatment-related mortality among pae-diatric cancer deaths: a population based analysis. Br J Cancer. 2017;116:540–5.
https://doi.org/10.1038/bjc.2016.443 DOI: https://doi.org/10.1038/bjc.2016.443
Christensen MS, Heyman M, Möttönen M, et al. Treatment-related death in childhood acute lymphoblastic leukaemia in the Nordic countries: 1992–2001. Br J Haema-tol. 2005;131:50–8.
https://doi.org/10.1111/j.1365-2141.2005.05736.x DOI: https://doi.org/10.1111/j.1365-2141.2005.05736.x
Riley LC, Hann IM, Wheatley K, et al. Treatment-related deaths during induction and first remission of acute myeloid leukaemia in children treated on the Tenth Medical Research council Acute Myeloid Leukaemia Trial (MRC AML10). Br J Haematol. 1999;106:436–44.
https://doi.org/10.1046/j.1365-2141.1999.01550.x DOI: https://doi.org/10.1046/j.1365-2141.1999.01550.x
Hamre MR, Williams J, Chuba P, et al. Early deaths in childhood cancer. Med Pediatr On-col. 2000;34:343–7. DOI: https://doi.org/10.1002/(SICI)1096-911X(200005)34:5<343::AID-MPO5>3.0.CO;2-B
https://doi.org/10.1002/(SICI)1096-911X(200005)34:5%3C343::AID-MPO5%3E3.0.CO;2-B
Creutzig U, Zimmermann M, Reinhardt D, et al. Early deaths and treatment-related mortal-ity in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98. J Clin Oncol. 2004;22:4384–93.
https://doi.org/10.1200/JCO.2004.01.191 DOI: https://doi.org/10.1200/JCO.2004.01.191
Gibson P, Pole JD, Lazor T, et al. Treatment-related mortality in newly diagnosed pediatric cancer: a population-based analysis. Cancer Med. 2018;7:707–15.
https://doi.org/10.1002/cam4.1362 DOI: https://doi.org/10.1002/cam4.1362
Hasle H, Kaspers GJL. Strategies for reducing the treatment-related physical burden of childhood acute myeloid leukaemia – a review. Br J Haematol. 2017;176(2):168–78.
https://doi.org/10.1111/bjh.14419 DOI: https://doi.org/10.1111/bjh.14419
Ethier MC, Blanco E, Lehrnbecher T, et al. Lack of clarity in the definition of treatment-related mortality: pediatric acute leukemia and adult acute promyelocytic leu-kemia as examples. Blood. 2011;118:5080–3.
https://doi.org/10.1182/blood-2011-07-363333 DOI: https://doi.org/10.1182/blood-2011-07-363333
O’Connor D, Bate J, Wade R, et al. Infection-related mortality in children with acute lym-phoblastic leukemia: an analysis of infectious deaths on UKALL2003. Blood. 2014;124:1056–61.
https://doi.org/10.1182/blood-2014-03-560847 DOI: https://doi.org/10.1182/blood-2014-03-560847
Klein K, van Litsenburg RRL, de Haas V, et al. Causes of early death and treatment-related death in newly diagnosed pediatric acute myeloid leukemia: recent experiences of the Dutch Childhood Oncology Group. Pediatr Blood Cancer. 2020;67:1–10.
https://doi.org/10.1002/pbc.28099 DOI: https://doi.org/10.1002/pbc.28099
Oskarsson T, Söderhäll S, Arvidson J, et al. Treatment-related mortality in relapsed child-hood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2018;65:1–10.
https://doi.org/10.1002/pbc.26909 DOI: https://doi.org/10.1002/pbc.26909
Schrøder H, Rechnitzer C, Wehner PS, et al. Danish childhood cancer registry. Clin Epi-demiol. 2016;8:461–4.
https://doi.org/10.2147/CLEP.S99508 DOI: https://doi.org/10.2147/CLEP.S99508
Schmidt M, Pedersen L, Sørensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol. 2014;29:541–9.
https://doi.org/10.1007/s10654-014-9930-3 DOI: https://doi.org/10.1007/s10654-014-9930-3
Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P. International classification of child-hood cancer, third edition. Cancer. 2005;103:1457–67.
https://doi.org/10.1002/cncr.20910 DOI: https://doi.org/10.1002/cncr.20910
Hassan H, Rompola M, Glaser AW, et al. Validation of a classification system for treat-ment-related mortality in children with cancer. BMJ Paediatr Open. 2017;1:1–6.
https://doi.org/10.1136/bmjpo-2017-000082 DOI: https://doi.org/10.1136/bmjpo-2017-000082
McHugh M L. Interrater reliability: the kappa statistic. Biochem Med. 2012;22:276–82.
https://doi.org/10.11613/BM.2012.031 DOI: https://doi.org/10.11613/BM.2012.031
Toft N, Birgens H, Abrahamsson J, et al. Results of NOPHO ALL2008 treatment for patients aged 1–45 years with acute lymphoblastic leukemia. Leukemia. 2018;32:606–15.
https://doi.org/10.1038/leu.2017.265 DOI: https://doi.org/10.1038/leu.2017.265
Björk-Eriksson T, Boström M, Bryngelsson I-L, et al. Mortality among pediatric patients with acute lymphoblastic leukemia in Sweden from 1988 to 2017. JAMA Netw Open. 2022;5:1–12.
https://doi.org/10.1001/jamanetworkopen.2022.43857 DOI: https://doi.org/10.1001/jamanetworkopen.2022.43857
Kumar R, Shandal V, Shamim SA, et al. Clinical applications of PET and PET/CT in pedia-tric malignancies. Expert Rev Anticancer Ther. 2010;10:755–68.
https://doi.org/10.1586/era.10.12 DOI: https://doi.org/10.1586/era.10.12
Jadvar H, Connolly LP, Fahey FH, et al. PET and PET/CT in pediatric oncology. Semin Nucl Med. 2007;37:316–31.
https://doi.org/10.1053/j.semnuclmed.2007.04.001 DOI: https://doi.org/10.1053/j.semnuclmed.2007.04.001
Becker C, Graf N, Grabow D, et al. Early deaths from childhood cancer in Germany 1980–2016. Cancer Epidemiol. 2020;65:1–7.
https://doi.org/10.1016/j.canep.2020.101669 DOI: https://doi.org/10.1016/j.canep.2020.101669
Green AL, Furutani E, Ribeiro KB, et al. Death within 1 month of diagnosis in childhood cancer: an analysis of risk factors and scope of the problem. J Clin Oncol. 2017;35:1320–7.
https://doi.org/10.1200/JCO.2016.70.3249 DOI: https://doi.org/10.1200/JCO.2016.70.3249
Lund B, Annåsberg AA, Heyman M, et al. Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemia on behalf of the Nordic Society of Paediatric Haematology and Oncology (NOPHO). Pediatr Blood Cancer. 2011;56:551–9.
https://doi.org/10.1002/pbc.22719 DOI: https://doi.org/10.1002/pbc.22719
Meeske KA, Ji L, Freyer DR, et al. Comparative toxicity by sex among children treated for acute lymphoblastic leukemia: a report from the children’s oncology group. Pe-diatr Blood Cancer. 2015;62:2140–9.
https://doi.org/10.1002/pbc.25628 DOI: https://doi.org/10.1002/pbc.25628
Additional Files
Published
How to Cite
License
Copyright (c) 2023 Marie C.L. Sørensen, Mie M. Andersen, Klaus Rostgaard, Kjeld Schmiegelow, Torben S. Mikkelsen, Peder S. Wehner, Marianne Olsen, Signe H. Søegaard, Lisa L. Hjalgrim
This work is licensed under a Creative Commons Attribution 4.0 International License.
Funding data
-
Børnecancerfonden
Grant numbers 2022-8040
